Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
7.75
+0.43 (5.87%)
At close: Nov 6, 2026, 4:00 PM EST
7.64
-0.11 (-1.42%)
After-hours: Nov 6, 2026, 7:30 PM EST
Immunic Employees
Immunic had 100 employees as of June 30, 2026. The number of employees increased by 10 or 11.11% compared to the same quarter last year. That makes Immunic the 31,477th largest employer in the world and 4,032nd in the United States.
Employees
100
Change (1Y)
10
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,115,660
Market Cap
105.74M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 100 | 10 | 11.11% |
| Mar 31, 2026 | 95 | 5 | 5.56% |
| Dec 31, 2025 | 92 | 1 | 1.10% |
| Sep 30, 2025 | 90 | 5 | 5.88% |
| Jun 30, 2025 | 90 | 5 | 5.88% |
| Mar 31, 2025 | 90 | 10 | 12.50% |
| Dec 31, 2024 | 91 | 14 | 18.18% |
| Sep 30, 2024 | 85 | 5 | 6.25% |
| Jun 30, 2024 | 85 | 10 | 13.33% |
| Mar 31, 2024 | 80 | 7 | 9.59% |
| Dec 31, 2023 | 77 | 11 | 16.67% |
| Sep 30, 2023 | 80 | 15 | 23.08% |
| Jun 30, 2023 | 75 | 15 | 25.00% |
| Mar 31, 2023 | 73 | 18 | 32.73% |
| Dec 31, 2022 | 66 | 11 | 20.00% |
| Sep 30, 2022 | 65 | 13 | 25.00% |
| Jun 30, 2022 | 60 | 15 | 33.33% |
| Mar 31, 2022 | 55 | 15 | 37.50% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PMV Pharmaceuticals | 54 |
| OnKure Therapeutics | 45 |
| Milestone Pharmaceuticals | 38 |
| Anavex Life Sciences | 34 |
| TuHURA Biosciences | 22 |
| Unicycive Therapeutics | 22 |
| Black Diamond Therapeutics | 21 |
| Equillium | 15 |
IMUX News
- 2 days ago - Immunic Transcript: R&D Day 2026 - Transcripts
- 2 days ago - Immunic Slides: FY 2026 - Filings
- 5 days ago - Immunic to Participate in Investor Conferences in November - PRNewsWire
- 9 days ago - Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026 - PRNewsWire
- 15 days ago - Immunic initiated with an Overweight at Cantor Fitzgerald - TheFly
- 15 days ago - Immunic initiated with an Overweight at Cantor Fitzgerald - TheFly
- 17 days ago - Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting - PRNewsWire
- 19 days ago - Immunic Slides: Investor presentation - Filings